These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30571316)

  • 1. Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow.
    Ozawa K; Packwood W; Varlamov O; Qi Y; Xie A; Wu MD; Ruggeri Z; López JA; Lindner JR
    Circ Cardiovasc Imaging; 2018 Nov; 11(11):e007913. PubMed ID: 30571316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated LDL Cholesterol Increases Microvascular Endothelial VWF and Thromboinflammation After Myocardial Infarction.
    Ozawa K; Packwood W; Varlamov O; Muller M; Xie A; Wu MD; Abraham-Fan RJ; López JA; Lindner JR
    Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):1041-1053. PubMed ID: 37128919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
    Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ADAMTS13 in acute myocardial infarction: cause or consequence?
    Eerenberg ES; Teunissen PF; van den Born BJ; Meijers JC; Hollander MR; Jansen M; Tijssen R; Beliën JA; van de Ven PM; Aly MF; Kamp O; Niessen HW; Kamphuisen PW; Levi M; van Royen N
    Cardiovasc Res; 2016 Aug; 111(3):194-203. PubMed ID: 27174213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of endothelial surface-associated von villebrand factor suppresses accelerate datherosclerosis after myocardial infarction.
    Ozawa K; Packwood W; Muller MA; Qi Y; Xie A; Varlamov O; McCarty OJ; Chung D; López JA; Lindner JR
    J Transl Med; 2024 May; 22(1):412. PubMed ID: 38693516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.
    Zhao B; Li J; Luo X; Zhou Q; Chen H; Shi H
    Tex Heart Inst J; 2011; 38(5):516-22. PubMed ID: 22163125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial CD40 Mediates Microvascular von Willebrand Factor-Dependent Platelet Adhesion Inducing Inflammatory Venothrombosis in ADAMTS13 Knockout Mice.
    Tahir S; Wagner AH; Dietzel S; Mannell H; Pircher J; Weckbach LT; Hecker M; Pohl U
    Thromb Haemost; 2020 Mar; 120(3):466-476. PubMed ID: 32135568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis.
    Shim CY; Liu YN; Atkinson T; Xie A; Foster T; Davidson BP; Treible M; Qi Y; López JA; Munday A; Ruggeri Z; Lindner JR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e002765. PubMed ID: 26156014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and Resolution of Pial Microvascular Thrombosis in a Mouse Model of Thrombotic Thrombocytopenic Purpura.
    Adili R; Holinstat M
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1817-1830. PubMed ID: 31340669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.
    Rybaltowski M; Suzuki Y; Mogami H; Chlebinska I; Brzoska T; Tanaka A; Banno F; Miyata T; Urano T
    Pflugers Arch; 2011 Jun; 461(6):623-33. PubMed ID: 21494805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib.
    Latifi Y; Moccetti F; Wu M; Xie A; Packwood W; Qi Y; Ozawa K; Shentu W; Brown E; Shirai T; McCarty OJ; Ruggeri Z; Moslehi J; Chen J; Druker BJ; López JA; Lindner JR
    Blood; 2019 Apr; 133(14):1597-1606. PubMed ID: 30692122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice.
    Gandhi C; Motto DG; Jensen M; Lentz SR; Chauhan AK
    Blood; 2012 Dec; 120(26):5224-30. PubMed ID: 22983446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B100/Low-Density Lipoprotein Regulates Proteolysis and Functions of von Willebrand Factor under Arterial Shear.
    Cao W; Abdelgawwad MS; Li J; Zheng XL
    Thromb Haemost; 2019 Dec; 119(12):1933-1946. PubMed ID: 31493779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Infarction Produces Sustained Proinflammatory Endothelial Activation in Remote Arteries.
    Moccetti F; Brown E; Xie A; Packwood W; Qi Y; Ruggeri Z; Shentu W; Chen J; López JA; Lindner JR
    J Am Coll Cardiol; 2018 Aug; 72(9):1015-1026. PubMed ID: 30139430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
    Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
    J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
    Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.
    Bonnefoy A; Daenens K; Feys HB; De Vos R; Vandervoort P; Vermylen J; Lawler J; Hoylaerts MF
    Blood; 2006 Feb; 107(3):955-64. PubMed ID: 16204318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
    Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
    J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.